RenovoRx Inc (RNXT) earnings · rev $1.1M
These earnings events as JSON? API free 100/dayRenovoRx Inc (RNXT) is a biotechnology company listed on US.
This RNXT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported RNXT revenue for 2025-12-31 was $1.1M. Net income was -$11.2M. Revenue was up 2511.6% from 2024-12-31 to 2025-12-31. RNXT currently screens at market cap $47.0M.
When the next RNXT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 2511.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full RNXT research stays on the stock page; the tape stays on the quote page.
RNXT earnings FAQ
What are RNXT's latest revenue and net income?
Latest cached RenovoRx Inc (RNXT) revenue for Dec 31, 2025 was $1.1M. Net income was -$11.2M. Statements: https://lician.com/financials/rnxt
What is RNXT's latest diluted EPS?
Latest cached RenovoRx Inc (RNXT) diluted EPS for Dec 31, 2025 was -$0.32.
What period does the latest RNXT earnings print cover?
The latest cached RenovoRx Inc (RNXT) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did RNXT revenue change from the prior cached period?
Cached RenovoRx Inc (RNXT) revenue was up 2511.6% from $43.0K (Dec 31, 2024) to $1.1M (Dec 31, 2025). Statements: https://lician.com/financials/rnxt
Where are RNXT earnings listed?
Cached earnings facts for RenovoRx Inc (RNXT) are listed at https://lician.com/earnings/rnxt. Statements: https://lician.com/financials/rnxt
Not investment advice.